Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen

NCT00638807 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

388

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Celecoxib
OTHER: Placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.